Abstract
With the everincreasing problem of multidrug resistance worldwide, concerns are growing regarding use of alternative compounds to supplement or modify the actions of antibiotics. Along with drug resistance, antibiotics also provide a number of side effects, diarrhea being a very prominent one. Antibiotic associated diarrhea (AAD) is difficult to manage and therefore concepts like ‘probiotics’ have gained importance. In this respect, ‘prebiotics’, which are ‘food’ to ‘feed’ the healthy colonic flora, is an upcoming concept. Because antibiotics alter the normal intestinal flora, controlling the composition of the flora could be truly beneficial. Prebiotics are short chain carbohydrates that can alter the intestinal microbial flora to one rich in bifidobacteria and lactobacilli, the organisms that constitute ‘balanced healthy flora’ and resist gut colonizations by pathogenic flora and infections. The approach seems reasonable. Moreover, prebiotic compounds can be easily incorporated into foodstuffs unlike probiotics. Despite the availability of many natural compounds with prebiotic activity, only inulin and fructo-oligosaccharides have successfully met the criteria to be labeled as prebiotics with substantial evidence. Therefore, it is much early to suppose that prebiotics will markedly change the fate of AADs, even though their potential to restore gut microbial balance is definite. Continuous research studying the effects of more such compounds is required to substantiate the several physiological benefits of prebiotics.
Keywords: AAD, balanced, bifidogenic, colonic, healthy microflora, inulin, prebiotics.
Anti-Infective Agents
Title:Prebiotics: A New Hope Against Antibiotic Associated Diarrhea
Volume: 12 Issue: 2
Author(s): Tuhina Banerjee and Amitabha Bhattacharjee
Affiliation:
Keywords: AAD, balanced, bifidogenic, colonic, healthy microflora, inulin, prebiotics.
Abstract: With the everincreasing problem of multidrug resistance worldwide, concerns are growing regarding use of alternative compounds to supplement or modify the actions of antibiotics. Along with drug resistance, antibiotics also provide a number of side effects, diarrhea being a very prominent one. Antibiotic associated diarrhea (AAD) is difficult to manage and therefore concepts like ‘probiotics’ have gained importance. In this respect, ‘prebiotics’, which are ‘food’ to ‘feed’ the healthy colonic flora, is an upcoming concept. Because antibiotics alter the normal intestinal flora, controlling the composition of the flora could be truly beneficial. Prebiotics are short chain carbohydrates that can alter the intestinal microbial flora to one rich in bifidobacteria and lactobacilli, the organisms that constitute ‘balanced healthy flora’ and resist gut colonizations by pathogenic flora and infections. The approach seems reasonable. Moreover, prebiotic compounds can be easily incorporated into foodstuffs unlike probiotics. Despite the availability of many natural compounds with prebiotic activity, only inulin and fructo-oligosaccharides have successfully met the criteria to be labeled as prebiotics with substantial evidence. Therefore, it is much early to suppose that prebiotics will markedly change the fate of AADs, even though their potential to restore gut microbial balance is definite. Continuous research studying the effects of more such compounds is required to substantiate the several physiological benefits of prebiotics.
Export Options
About this article
Cite this article as:
Banerjee Tuhina and Bhattacharjee Amitabha, Prebiotics: A New Hope Against Antibiotic Associated Diarrhea, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/2211352511999131128152601
DOI https://dx.doi.org/10.2174/2211352511999131128152601 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
Call for Papers in Thematic Issues
An Overview of Drugs for Multiple Targets and Variants of SARS-CoV-2 Through Artificial Intelligence, Machine Learning, Deep Learning, and Experimental Analysis
The emergence and rapid evolution of SARS-CoV-2 variants have posed significant challenges in the ongoing fight against the COVID-19 pandemic. The development of effective treatments for multiple viral targets and variants demands innovative approaches, including artificial intelligence (AI), machine learning (ML), and deep learning (DL) techniques. This special issue aims ...read more
Emerging trends in infectious disease and its management
Despite the triumph of Antibiotics in the 20th century, the rise of infectious disease is beyond control with compelling recent evidence of COVID-19. WHO declares mpox virus a public health emergency of international concern in August 2024, yet another example of resurgence of infectious disease. The Plague, black death, smallpox ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Management of Chordoma
Current Drug Therapy Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas
Current Clinical Pharmacology Role of Progastrins and Gastrins and Their Receptors in GI and Pancreatic Cancers: Targets for Treatment
Current Pharmaceutical Design Is Small Really Beautiful? Nanosensors and Low Abundance Biomarkers for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine <i>Citrus</i> Flavonoids and Autoimmune Diseases: A Systematic Review of Clinical Studies
Current Medicinal Chemistry 19F: A Versatile Reporter for Non-Invasive Physiology and Pharmacology Using Magnetic Resonance
Current Medicinal Chemistry New Aspects of Regulatory Signaling Pathways and Novel Therapies in Pancreatic Cancer
Current Molecular Medicine Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily
Current Drug Metabolism Pharmacogenomics of Arylamine N-acetyltransferase
Current Pharmacogenomics Microscopic Evidence of the Behavior of pH-sensitive Food-grade Polymeric Delivery Systems
Current Nutraceuticals Novel Polymethoxylated Chalcones as Potential Compounds Against KRAS-Mutant Colorectal Cancers
Current Pharmaceutical Design Ultrasound Contrast Imaging in Cancer –Technical Aspects and Prospects
Current Molecular Imaging (Discontinued) Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Heat Shock Protein 70s as Potential Molecular Targets for Colon Cancer Therapeutics
Current Medicinal Chemistry Inflammasome, Inflammation and Cancer: An Interrelated Pathobiological Triad
Current Drug Targets Simultaneous Separation, Quantitation, and Determination of the Dissociation Constant of Five Components of Ixeris sonchifolia by Microemulsion Electrokinetic Chromatography
Current Pharmaceutical Analysis From the Deepest Sea Shelf to the Uppermost Kitchen Cabinet Shelf: The Quest for Novel TNF-α Inhibitors
Current Topics in Medicinal Chemistry Mucosal Vaccine Vectors: Replication-Competent Versus Replication-Deficient Poxviruses
Current Pharmaceutical Design Phosphatidylinositol 3-Kinase Isoforms as Novel Drug Targets
Current Drug Targets Diagnostic Performance of Magnetic Resonance Cholangiopancreatography (MRCP) for Biliopancreatic Cancer
Current Medical Imaging